MedPage Today on MSN
Single Midlife PSA Test May Identity Long-Term Prostate Cancer Risk
Many men with low levels could be spared from invasive procedures and frequent testing ...
Value of PSA measured in middle age in predicting diagnosis of advanced prostate cancer in an unscreened population No significant financial relationships to disclose. This is an ASCO Meeting Abstract ...
PSA density (PSAD) predicts pathologic upstaging following radical prostatectomy (RP) for prostate cancer, a study found. The finding suggests that PSAD may be an additional parameter that clinicians ...
New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.
The REIMAGINE study, published today in BMJ Oncology, is the first study to use MRI scans with prostate specific antigen (PSA) density to assess the need for further standard NHS tests. Of the 29 ...
Robotic-assisted transperineal fusion biopsy led to relatively low rates of prostate cancer upgrading and downgrading in a ...
Using MRI scans in screening for prostate cancer could detect tumours missed by prostate-specific antigen (PSA) blood testing alone, according to a major new study from University College London (UCL) ...
The REIMAGINE study, published today in BMJ Oncology, is the first study to use MRI scans with prostate specific antigen (PSA) density to assess the need for further standard NHS tests. Of the 29 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results